Brunswick Station Dental Center | |
8755 Chaffee Rd. Suite 103 Brunswick TN 38014 | |
(901) 382-9704 | |
(901) 382-9706 |
Full Name | Brunswick Station Dental Center |
---|---|
Speciality | Dentist - General Practice |
Location | 8755 Chaffee Rd., Brunswick, Tennessee |
Authorized Official Name and Position | William E. Ferguson (DOCTOR) |
Authorized Official Contact | 9013829704 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Brunswick Station Dental Center 8755 Chaffee Rd. Suite 103 Brunswick TN 38014 Ph: (901) 382-9704 | Brunswick Station Dental Center 8755 Chaffee Rd. Suite 103 Brunswick TN 38014 Ph: (901) 382-9704 |
NPI Number | 1861664872 |
---|---|
Provider Enumeration Date | 03/31/2008 |
Last Update Date | 03/31/2008 |
Identifier | Type | State | Issuer |
---|---|---|---|
1861664872 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | 2131 (Tennessee) | Primary |
News Archive
A new preprint, available on the medRxiv* server, describes how researchers found at least a third of infected individuals to be asymptomatic, but that a fifth of them successfully passed on the virus to others. In comparison, about a quarter of symptomatic cases did so, especially when the symptoms included fever, cough and shortness of breath. In these circumstances, up to 30% of them transmitted the virus.
ClearCount Medical Solutions and Medline Industries, Inc. today announced that its newest customer, the VA Pittsburgh Healthcare system will help prevent retained surgical sponge incidents with the use of the SmartSponge System®. The SmartSponge System is part of ClearCount's radio-frequency identification -based platform that uniquely identifies each sponge so that they can be easily counted and detected.
Organ-on-Chip specialist CN Bio has signed a distribution agreement with Sydney-based AXT Pty. Ltd., Australia's leading supplier of high technology scientific equipment. The agreement will see AXT distribute CN Bio's innovative bioengineering products to medical researchers in academia and industry throughout Australia, New Zealand and the South Pacific region.
Researchers within the Observational Health Data Services and Informatics (OHDSI) community were recently awarded a $10 million contract from the U.S. Food and Drug Administration (FDA) to provide support to the Biologics Effectiveness and Safety (BEST) program, which was launched by the FDA Center for Biologics Evaluation and Research (CBER) in 2017.
Stem cell biology takes another exciting leap forward as scientists report that normal tissue cells can be reprogrammed to exhibit many of the properties that are characteristic of embryonic stem cells, including the ability to give rise to multiple cell types and contribute to the germline.
› Verified 3 days ago